重症流感肺炎危重患者中曲霉病的范围:一项多中心队列研究
这项回顾性多中心队列研究纳入2009至2018年法国5个ICU收治的524例重症流感(呼吸道RT-PCR阳性)患者,其中450例(86%)需机械通气。多因素模型显示肝硬化(OR=6.7)、血液恶性肿瘤(OR=3.3)、甲型H1N1pdm09亚型(OR=3.9)和需用血管活性药(OR=4.1)与曲霉阳性培养独立相关。曲霉阳性患者院内死亡率36% vs 21%(P=0.09)。作者认为拟诊侵袭性肺曲霉病是重症流感的相对少见并发症,需统一诊断定义并开展前瞻性研究。
要点
- 524例中450例(86%)需机械通气,提示该队列以重症呼吸衰竭为主。
- 作者指出重症流感与侵袭性肺曲霉病关联仍有争议,统一诊断定义是当务之急。
适用人群与场景
- 2009至2018年法国5个ICU收治的重症流感患者,诊断依据为呼吸道逆转录聚合酶链反应(RT-PCR)阳性,共524例。
- 其中450例(86%)需要机械通气。
诊断标准与关键阈值
- 曲霉阳性定义为下呼吸道标本培养出曲霉(Asp+),共28例(5.3%)。
- 原文未提及AspICU算法的具体条目、界值或启动/停止阈值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 肝硬化、血液恶性肿瘤、甲型H1N1pdm09流感病毒亚型、需用血管活性药为曲霉阳性培养的独立危险因素,原文未给出针对这些情况的特定处理推荐。
- 曲霉阳性患者院内死亡率36%,原文未给出针对曲霉阳性的特定治疗推荐。
研究设计与关键结果
- 研究类型:回顾性多中心队列研究,5个法国ICU,2009至2018年,共524例重症流感患者。
- 院内死亡率:曲霉阳性36% vs 曲霉阴性21%(p=0.09)。
证据类型、等级与局限
- 证据类型:回顾性多中心队列研究。
对床旁实践的改变
- 在重症流感ICU患者中,拟诊侵袭性肺曲霉病相对少见(1.9%),不应仅凭流感诊断常规经验性抗曲霉治疗,原文未给出治疗推荐。
- 对合并肝硬化、血液恶性肿瘤、甲型H1N1pdm09感染或需用血管活性药的重症流感患者,应提高对曲霉阳性下呼吸道标本的警惕。
- 曲霉阳性与院内死亡率升高相关但未达统计学显著(36% vs 21%,p=0.09),不能据此确定因果关系。
- 原文强调需统一侵袭性肺曲霉病诊断定义并开展前瞻性研究,当前证据不足以改变常规筛查或治疗策略。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine the frequency and prognosis of invasive pulmonary aspergillosis in critically ill patients with severe influenza pneumonia.
DESIGN: Retrospective multicenter cohort study.
SETTING: Five French ICUs.
PATIENTS: Patients with influenza admitted to ICU between 2009 and 2018.
MEASUREMENTS AND MAIN RESULTS: Of the 524 patients admitted for severe influenza diagnosed with a positive airway reverse-transcriptase polymerase chain reaction test, 450 (86%) required mechanical ventilation. A lower respiratory tract sample yielded with Aspergillus (Asp+) in 28 patients (5.3%). Ten patients (1.9%) were diagnosed with putative or proven invasive pulmonary aspergillosis, based on the validated AspICU algorithm. A multivariate model was built to identify independent risk factors for Aspergillus-positive pulmonary culture. Factors independently associated with Aspergillus-positive culture were liver cirrhosis (odds ratio = 6.7 [2.1-19.4]; p < 0.01), hematologic malignancy (odds ratio = 3.3 [1.2-8.5]; p = 0.02), Influenza A(H1N1)pdm09 subtype (odds ratio = 3.9 [1.6-9.1]; p < 0.01), and vasopressor requirement (odds ratio = 4.1 [1.6-12.7]; p < 0.01). In-hospital mortality of Asp+ patients was 36% versus 21% in patients without Aspergillus-positive pulmonary culture (p = 0.09).
CONCLUSIONS: In this large retrospective multicenter cohort of critically ill patients, putative invasive pulmonary aspergillosis according to AspICU algorithm was a relatively rare complication of influenza. Patients at higher risk of Aspergillus pulmonary colonization included those with liver cirrhosis, hematologic malignancy, H1N1pdm09 influenza A virus, and requiring vasopressors. Our results provide additional data on the controversial association between severe influenza and invasive pulmonary aspergillosis. Reaching a consensual definition of invasive pulmonary aspergillosis becomes mandatory and confers further prospective research.
参考来源
- Coste A, Frérou A, Raute A, et al. The Extent of Aspergillosis in Critically Ill Patients With Severe Influenza Pneumonia: A Multicenter Cohort Study. Crit Care Med. 2021. PMID: 33591000. doi:10.1097/CCM.0000000000004861
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。